Table 6.

Multivariate Cox analysis of factors affecting late recurrent EOC

	B	SE	Wald	HR (95% CI)	P
Treatment course	1.018	0.252	16.279	2.768(1.688–4.539)	0.000
Apatinib	−0.968	0.285	11.552	0.380(0.217–0.644)	0.001
Recurrent lesions	0.626	0.305	4.206	1.870(1.028–3.403)	0.04
Surgery	0.156	0.273	0.326	1.168(0.685–1.994)	0.568
CA125 level	0.009	0.274	0.001	1.009(0.590–1.726)	0.974
Ascites	−0.170	0.248	0.326	0.844(0.518–1.373)	0.494